中文 | English
Return
Total: 35 , 1/4
Show Home Prev Next End page: GO
Author:(Hongying LIANG)

2.Effects of angiotensin Ⅱ on apoptosis and apoptosis genes in vascular endothelial cells and the influences of enoxaparin on the effects

Xuguo LIANG ; Hongying CHEN

Chinese Journal of Geriatrics 2000;0(04):-

3.GC/MS Analysis of Volatile Constituents of Radix Isatidis

Hongying XU ; Xiaomei YU ; Yizeng LIANG ; Lunzhao YI

China Pharmacy 2005;0(16):-

4.Considerations on Ethical Issues of Clinical Decision Based on Case Study

Hongying LI ; Lizhi LIANG ; Yitao XU ; Wenjie SUI ; Qi HE

Chinese Medical Ethics 2015;(4):575-578

5.Effects of different speeds and ways of instillation on bladder volume, pressure and pelvic nerve firing

Huanling LAI ; Zhijian LIANG ; Qinghe WU ; Ping HUANG ; Hongying CAO

Chinese Journal of Pathophysiology 2015;(2):379-384

6.Considerations on Ethical Issues of Clinical Research Based on Case Study

Lizhi LIANG ; Huaqi CHAI ; Hongying LI ; Yitao XU ; Wenjie SUI

Chinese Medical Ethics 2015;(3):318-321

7.Study of correlation of pathology factors and prognosis of gastrointestinal stroma tumor

Wenqi BAI ; Zhetao MI ; Xiaobo LIANG ; Hongying LI ; Yanfeng XI

Cancer Research and Clinic 2009;21(5):341-342,345

8.The effect of EBV latent membrane protein 1 on proliferation and cell cycle of nasopharyngeal carcinoma cells

Peichun HUANG ; Hongying LIANG ; Huihua DENG ; Kangrong CAI ; Minglun ZHAO

Chinese Journal of Pathophysiology 1989;0(06):-

9.Effects of EBV infection on growth and apoptosis of nasopharyngeal carcinoma cell line

Peichun HUANG ; Hongying LIANG ; Huihua DENG ; Minglun ZHAO

Chinese Journal of Pathophysiology 2000;0(07):-

10.Two cases of cutaneous lymphadenoma: a histological and immunohistological study

Liuqing CHEN ; Hongying CHEN ; Ling MA ; Bilin DONG ; Yihua JIANG ; Liang ZHANG ; Weizhen WANG ; Yiqun DUAN

Chinese Journal of Dermatology 2009;42(7):445-447

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 35 , 1/4 Show Home Prev Next End page: GO